P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO
I. H. Hiemstra,
K. Santegoets,
M. L. Janmaat,
W. Ten Hagen,
S. Van Dooremalen,
B. E. De Goeij,
S. Bosgra,
A. K. Sasser,
E. C. Breij
Affiliations
I. H. Hiemstra
1 Genmab BV, Utrecht, Netherlands
K. Santegoets
1 Genmab BV, Utrecht, Netherlands
M. L. Janmaat
1 Genmab BV, Utrecht, Netherlands
W. Ten Hagen
1 Genmab BV, Utrecht, Netherlands
S. Van Dooremalen
1 Genmab BV, Utrecht, Netherlands
B. E. De Goeij
1 Genmab BV, Utrecht, Netherlands
S. Bosgra
1 Genmab BV, Utrecht, Netherlands
A. K. Sasser
2 Genmab US, Inc, Plainsboro, NJ, United States of America
